Analystreport

Cidara Therapeutics (NASDAQ:CDTX) had its "neutral" rating reaffirmed by analysts at Guggenheim.

Cidara Therapeutics, Inc.  (CDTX) 
Last cidara therapeutics, inc. earnings: 3/4 05:55 am Check Earnings Report
US:NASDAQ Investor Relations: ir.cidara.com